Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral CAN1012 injection plus toripalimab in advanced solid tumors (Ib/IIa)
CTR20241555Phase 2Active
- Sponsor
- Conway Biotech
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CAN1012 in Nonhematologic neoplasms, sponsored by Conway Biotech. Started Jun 2024; status: active.
02
Drugs
CAN1012
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20241555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241555.